Blair William & CO Abbott Laboratories Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Blair William & CO holds 1,774,236 shares of ABT stock, worth $183 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

1,774,236

Previous 1,740,207 1.96%

Holding current value

$183 Million

Previous $192 Million 5.28%

% of portfolio

0.64%

Previous 0.66%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $3.73 Million - $4.12 Million	34,029 Added 1.96%	1,774,236 $202 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $2.4 Million - $2.94 Million	26,601 Added 1.55%	1,740,207 $192 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $12.5 Million - $14.9 Million	-130,373 Reduced 7.07%	1,713,606 $166 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $1.96 Million - $2.19 Million	-19,471 Reduced 1.04%	1,843,979 $201 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $7.08 Million - $8.34 Million	-73,137 Reduced 3.78%	1,863,450 $189 Million

Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $6.78 Million - $7.95 Million	71,287 Added 3.82%	1,936,587 $213 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $2.37 Million - $2.75 Million	24,534 Added 1.33%	1,865,300 $180 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $2.76 Million - $3.33 Million	-27,032 Reduced 1.45%	1,840,766 $200 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $3.77 Million - $4.6 Million	-33,068 Reduced 1.74%	1,867,798 $221 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $9.62 Million - $11.8 Million	83,276 Added 4.58%	1,900,866 $268 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $5.46 Million - $6.04 Million	46,776 Added 2.64%	1,817,590 $215 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $7.81 Million - $9.19 Million	73,799 Added 4.35%	1,770,814 $205 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $9.85 Million - $11.6 Million	-90,522 Reduced 5.06%	1,697,015 $203 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $11.9 Million - $13 Million	113,328 Added 6.77%	1,787,537 $196 Million
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $13.4 Million - $16.3 Million	146,445 Added 9.59%	1,674,209 $182 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $11 Million - $14.1 Million	144,063 Added 10.41%	1,527,764 $140 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $96,177 - $140,637	-1,531 Reduced 0.11%	1,383,701 $109 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $4.46 Million - $4.96 Million	56,795 Added 4.28%	1,385,232 $120 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $972,750 - $1.05 Million	11,886 Added 0.9%	1,328,437 $111 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $2.25 Million - $2.63 Million	30,911 Added 2.4%	1,316,551 $111 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $5.62 Million - $6.79 Million	84,870 Added 7.07%	1,285,640 $103 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $17.5 Million - $19.8 Million	266,596 Added 28.54%	1,200,770 $86.9 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $2.85 Million - $3.44 Million	46,903 Added 5.29%	934,174 $68.5 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $1.2 Million - $1.32 Million	20,783 Added 2.4%	887,271 $54.1 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $5.31 Million - $6 Million	94,304 Added 12.21%	866,488 $51.9 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $654,896 - $701,134	12,200 Added 1.61%	772,184 $44.1 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $36.5 Million - $40.8 Million	759,984	759,984 $40.6 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account